Beamtree (ASX:BMT) has inked a A$600,000 bundle of contracts across Australia, Canada, and the U.K. to reportedly automate hospital clinical coding operations.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
Clinical coding refers to the standardised lexicon of alphanumeric codes used by hospitals around the world to effectively ‘shorthand’ specific diagnoses and other patient datum.
According to Beamtree – which didn’t provide a source – clinical coding errors by human hand cost hospital reimbursements some A$20B globally.
“Each contract is subject to the usual rights of termination for non-performance,” Beamtree added on Monday.
Shares jumped 8.7% to 25cps, showing a healthy reaction, however, that was on turnover of only $2,000 according to a third-party service porting Morningstar data. In other words: The stock is straddled by illiquidity.
This isn’t Beamtree’s first foray into the medical space. It recently expanded into Saudi Arabia with the same modus operandi.
The big question, of course, will be if Beamtree’s AI is any good. Even the “AI” models advertised as being the most advanced on the market frequently make mistakes. True believers generally try to avoid talking about that.
Beamtree, of course, sees a way for hospitals to spend more time on care, by automating manual data entry jobs. A handy pitch, but if they can pull it off, one that probably does pose a chunky value proposition.
More market news
51st State: What is Trump’s endgame with tariffs – and what will it mean for Canada?
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
“Autonomous coding will be a material driver of our future growth and these contract wins provide a foundation for this pioneering product,” Beamtree CEO Marek Stepniak said.
“I want to thank our customers in supporting this innovation.”
By that, Stepniak means the hospitals adopting the tech. Make of that what you will.
BMT last traded at 25cps.
Join the discussion: See what HotCopper users are saying about Beamtree and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。